Published data on humans report either mutations of Guanine nucleotide-binding protein Gq subunit α (GNAQ), as in uveal melanoma, or inactivation of NF2/merlin, as in the tumor-prone neurofibromatosis syndrome. This evidence concerns the gene NF2 and uveal melanoma.